Proficio Capital Partners LLC Takes Position in Trupanion, Inc. (NASDAQ:TRUP)

Proficio Capital Partners LLC purchased a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 20,244 shares of the financial services provider's stock, valued at approximately $976,000.

Several other hedge funds also recently modified their holdings of the company. SBI Securities Co. Ltd. acquired a new position in Trupanion during the fourth quarter worth about $25,000. Jones Financial Companies Lllp boosted its position in shares of Trupanion by 71.7% during the 4th quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider's stock valued at $27,000 after purchasing an additional 238 shares in the last quarter. Quest Partners LLC acquired a new position in shares of Trupanion in the 3rd quarter worth approximately $37,000. Wilmington Savings Fund Society FSB bought a new stake in shares of Trupanion in the 3rd quarter worth approximately $54,000. Finally, KBC Group NV acquired a new stake in Trupanion during the fourth quarter valued at approximately $75,000.

Trupanion Trading Down 2.1 %

Trupanion stock traded down $0.81 during midday trading on Tuesday, reaching $37.80. The stock had a trading volume of 440,148 shares, compared to its average volume of 639,507. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. The firm has a market cap of $1.61 billion, a price-to-earnings ratio of -164.35, a PEG ratio of 6.02 and a beta of 1.70. The firm's fifty day simple moving average is $41.54 and its two-hundred day simple moving average is $46.71.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). The business had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. Equities analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Fawwad Qureshi sold 1,373 shares of the firm's stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total transaction of $46,984.06. Following the completion of the sale, the chief financial officer now directly owns 2,416 shares in the company, valued at approximately $82,675.52. This trade represents a 36.24 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Margaret Tooth sold 4,000 shares of the business's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $37.17, for a total transaction of $148,680.00. Following the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at $4,415,201.28. The trade was a 3.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 29,984 shares of company stock worth $999,042. 5.50% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Piper Sandler decreased their price target on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Stifel Nicolaus cut their target price on Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research report on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $46.60.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.